These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36558987)

  • 1. Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance.
    Pop G; Farcaș A; Butucă A; Morgovan C; Arseniu AM; Pumnea M; Teodoru M; Gligor FG
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
    di Mauro G; Zinzi A; Scavone C; Mascolo A; Gaio M; Sportiello L; Ferrajolo C; Rafaniello C; Rossi F; Capuano A
    Drug Saf; 2021 Mar; 44(3):337-349. PubMed ID: 33351170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database.
    Rastogi S; Kalaiselvan V; Bin Jardan YA; Zameer S; Sarwat M
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System.
    Wei C; Yin W; He Z; Wu B
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cataracts and statins. A disproportionality analysis using data from VigiBase.
    Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
    Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System.
    Scavone C; Mascolo A; Ruggiero R; Sportiello L; Rafaniello C; Berrino L; Capuano A
    Front Pharmacol; 2020; 11():428. PubMed ID: 32351386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular toxicity of colchicine combined with statins: a real-world study based on the FDA adverse event reporting system database from 2004-2023.
    Liu Y; Wei C; Yuan Y; Zou D; Wu B
    Front Pharmacol; 2024; 15():1418498. PubMed ID: 39130635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization.
    Khurana A; Arora MK; Dubey H
    Daru; 2023 Dec; 31(2):107-118. PubMed ID: 37221442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-marketing safety surveillance of erenumab: new insight from Eudravigilance.
    Liang D; Sessa M
    Expert Opin Drug Saf; 2022 Sep; 21(9):1205-1210. PubMed ID: 35236231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
    van Hunsel F; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):26-32. PubMed ID: 19953500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study.
    Pozsgai K; Szűcs G; Kőnig-Péter A; Balázs O; Vajda P; Botz L; Vida RG
    Front Pharmacol; 2022; 13():964399. PubMed ID: 36147337
    [No Abstract]   [Full Text] [Related]  

  • 17. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.
    Capogrosso Sansone A; Convertino I; Galiulo MT; Salvadori S; Pieroni S; Knezevic T; Mantarro S; Marino A; Hauben M; Blandizzi C; Tuccori M
    Drug Saf; 2017 Oct; 40(10):895-909. PubMed ID: 28681266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System.
    Barbieri MA; Sorbara EE; Russo G; Cicala G; Franchina T; Santarpia M; Silvestris N; Spina E
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
    Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
    Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.
    Cham S; Koslik HJ; Golomb BA
    Drug Saf Case Rep; 2016 Dec; 3(1):1. PubMed ID: 27747681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.